%0 Editorial
%T Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions.
%A Ljubimova JY
%A Holler E
%A Black KL
%A Ljubimov AV
%J Nanomedicine (Lond)
%V 0
%N 0
%D 2024 Aug 7
%M 39109486
%F 6.096
%R 10.1080/17435889.2024.2380241